This quarter's round-up of cutting-edge cancer research includes a way to fight chemo brain, controlling cancer cell death, and...
The treatment of cutaneous melanoma has been profoundly transformed by the advent of targeted therapy and immunotherapy, which have...
As the spring weather encourages the planting of flowers, vegetables, and herbs, even careful gardeners may see weeds creeping...
Earlier this month, over 21,000 researchers, clinicians, patients, and other stakeholders gathered at the AACR Annual Meeting 2023 to...
The 2015 approval of an immune checkpoint inhibitor for renal cell carcinoma (RCC) provided a much-needed new treatment option...
With the approval of new anticancer therapeutics, more treatment options become available for patients. Some therapies are new to...
As we welcome spring, enjoy the latest round of editors’ picks selected by the editors of AACR’s 10 journals....
The immune system is designed to operate like a well-oiled machine. With a myriad of distinct cell types, a...
As February gives way to March, we bring you the latest round of editors’ picks selected by the editors...
To kick off the new year, the editors of the 10 AACR journals highlighted two phase I clinical trials,...
The end of the year presents a unique opportunity to look back on recent accomplishments, take inventory of successes...